Quantcast

Latest Drug-eluting stent Stories

2014-10-20 08:31:41

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease MARLBOROUGH, Mass., Oct. 20, 2014 /PRNewswire/ -- As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER((TM)) Everolimus-Eluting Platinum...

2014-09-30 23:25:37

Latest report by ChinaMarketResearchReports.com, "China Interventional Cardiovascular Device Industry Report, 2014-2017" now available in their store. Dallas, TX (PRWEB) September 30, 2014 The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary...

2014-09-30 16:24:12

Peripheral Vascular Devices Will See Significant Uptake as Competitors Increasingly Focus on these Countries, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the markets for peripheral vascular (PV) devices in Brazil, Russia, India and China (BRIC) will see robust expansion as these economies expand and as endovascular techniques are increasingly favored over surgical procedures. Although revenues will...

2014-09-18 12:30:22

DUBLIN, Sept. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "China PTCA Balloon Market Investment Report, 2014-2016" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related...

2014-09-18 04:21:14

WASHINGTON, September 18, 2014 /PRNewswire/ -- The world's first and only dual therapy stent Prof. Stephen W.L. Lee presented two-year optical coherence tomography (OCT) findings and three-year clinical follow up from the EGO COMBO study, providing further evidence to support the healing benefits of the COMBO Dual Therapy Stent, the only drug eluting stent (DES) with active EPC capture technology. The findings were presented during the 26th...

2014-09-16 08:29:53

-- Differentiated Design Yields Excellent Tissue Healing and Sustained Safety Profile -- DURHAM, N.C., Sept. 16, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that three-year clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference being held in Washington, D.C., September 13-17....

2014-09-15 23:08:28

ChinaMarketResearchReports.com adds Latest Report on “China PTCA Balloon Market Investment Report, 2014-2016” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114907 Dallas, TX (PRWEB) September 15, 2014 PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations....

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-14 12:20:52

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept. 14, 2014 /PRNewswire/ -- Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE family of DES. The trial,...

2014-08-06 08:32:12

SINGAPORE, Aug. 6, 2014 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15"). Quarter Highlights and Recent Developments: -- Total revenue was US$80.2 million, representing a 5% growth from the quarter ended 30 June 2013 ("Q1 FY14")....


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin